 
        ASSESSMENT OF DEPRESSION IN THE ELDERLY Alina Rais, M.D. Associate Professor of Psychiatry Medical Director Geriatric Psychiatry Center University of Toledo Department of Psychiatry Demographic of Aging 1900 – Only 4% were 65 and older  2000 – Increased by 13% in elderly population  2050 – Projected increase of 22% in elderly population  US Population: age 65 and over 80 70 60 50 40 Millions 30 20 10 0 1900 1930 1960 1990 2025 2045 Mental Health in the Elderly  Elderly people have greater risk of mental illness  15-25% of elderly in the USA suffer from symptoms of mental illness  Age 65 and older – highest suicide risk MENTAL HEALTH IN THE ELDERLY Only 41% of the patients in community mental health are elderly  Only 2% seen in hospital and private setting  Only 1.5% of the direct costs for treating mental health are allocated for the elderly  One of the most common mental illnesses in the elderly is Depression Syndrome which includes the following symptoms: Physical Emotional Cognitive The NIH Consensus Depression:  Affects 6 million people or 1 in 6  Is not a normal fact of aging  Is associated with functional disability and suicide  Can alter the course of a general medical condition The NIH Consensus (Cont.) Depression:  Increases morbidity and mortality  It is a recurrent illness  Occurs more frequently in nursing homes Suicide in the Elderly  Elderly suicide up by 9% in the last decade  White males over 65 account for 81% of all suicides Profile for Highest Suicide Risk White male over 60  Divorced/single/widow  Poor social support  Unemployed  Medical problems  History of alcohol abuse  High school education  Access to guns  Depression: Underrecognized and Undertreated in the Elderly 70 Patients Percent (%) 60 50 40 Depression 30 20 10 0 Told Counseling Medication Physician ECT=electroconvulsive therapy ECT Maddux RE, Delrhim KK, Rapaport MH. CNS Spectr. Vol 8, No 12 (Suppl 3), 2003. Health Services Utilization in Depressed Elderly Patients Number Over 1 Year 20 15 10 Depressed Not Depressed 5 0 Visits Laboratory Tests Radiological Procedures Consultations Total *P,.001 after controlling for comorbidity, type of insurance, and the use of antidepressants ΥP=.008. N=3,481 primary care patients >65 years of age Adapted from: Luber MP, Meyers BS, Williams-Russo PG, et al Depression and service utlization in elderly primary care patients. Am J Geriatr Psychiatry 2001:2:169-176 Maddux RE, Delrahim KK, Rapaport MH. CNS Spectr. Vol 8, No 12 (Suppl 3). 2003. Number of Suicides Rates of Completed Suicide 80 70 60 50 40 30 20 10 0 Male Females 1014 2024 3034 4044 5054 6064 7074 8084 Total In the United States, 1994 Per 100,000 Adapted from: Hirschfeld RM, Russell JM. Assessment and treatment of suicidal patients. N Engl J Med. 1997;13:910-913. Prevalence of Late Life Depression          Elderly women are at increased risk Twice as many in women compared to men of same age Might be a subsyndromal presentation like dysthymia, dysphoria DSM IV – not age sensitive 6%-9% of patients in primary setting 17%-37% diagnosed with minor depression 10-15% of patients in acute care 30%-45% of patients in nursing homes 13% of residents in nursing homes who experience first episode of depression Other Consequences of DepressionPsychiatric Increased use of alcohol and sedatives  Reduced cognitive function  – Depressive “Pseudodementia” – Excess disability in Alzheimer’s disease and stroke  Elevated nonsuicidal mortality – In nursing homes – increased 59% – In MI patients-hazard ratio 5.74 – In stroke, COPD External/Underlying factors (examples): Preclinical dementia Poverty Low social support Medical illness Increased Risk for Incident Physical Illness Vascular disease (stroke, coronary artery disease) Cancer? Osteoporosis? Hip fracture Depression Health behaviors: Poor medication adherence Non-adherence to visual or hearing aids? Smoking and physical inactivity Poor participation in rehabilitation Features of the depressed state: Executive-type cognitive deficits Poor appetite, causing low body mass index Psychomotor retardation Apathy and motivational deficit Sleep disturbance Decreased pain threshold Sequelae of disability: Increased negative life events Loss of perceived control Low self-esteem Social activity restriction Strained interpersonal relationships Physical Disability Risk Factors in Development of Late Life Depression (Biopsychosocial Illness Model)  Biological Risk Factors - Female > male - Changes in neurotransmitter activity - Dysregulation of the HPA (hypothalamic, pituitary axis) - Dysregulation of thyroid function - Decreased secretion of growth hormone Risk Factors in Development of Late Life Depression (Biopsychosocial Illness Model) (Cont.) Desynchronization of circadian rhythms with sleep cycle disturbance  Physical aspects of medical illness  Polypharmacy  Psychological Risk Factors  Decreased social support  Decreased functionality  Placement in a nursing home  Life events, i.e. retirement Psychological Risk Factors (Cont.)  Changes in financial status  Bereavement  History of mental illness  Decreased self-esteem  Diagnosing depression in the elderly could be challenging  Elderly population received 20-30% of all prescribed medications  Experience decline of cognitive and functional capacity Barriers in Diagnosing Depression in Elderly Patients      Most of this group of patients are seen in primary care settings Despite extensive education, still the family doctors fail to diagnose depression Different syndrome presentations ( not classical symptoms of depression, sad less depression) Stigma Lack of recognition of depressive symptoms by patient and family (seen as part of getting old)  When evaluating the elderly depressed patient, we need to: – – – – – – Identify any prior psychiatric illness Identify comorbid illnesses Baseline medical history Overall cognitive capacity Identify current stressors Evaluate medication that might contribute to depression – Receive objective information from family/caregiver Different Presentation of Depression Classic form of major depressive disorder that meets the DSM IV-R criteria  Mask depression (somatic complaints, anxiety)  Subsyndromal presentation (minor symptoms, dysthymia)  Depression due to medical condition  Vascular depression  Diagnosis  MDD – Criteria for Depression DSM IV-TR  2 week period with 5 or more of the following with 1 being either depressed mood or loss of interest/pleasure – Depressed mood most of the day/every day (subjective or objective) – Diminished interest/pleasure – anhedonia – Weight loss or gain >5% in a month or change in appetite – Insomnia or hypersomnia nearly every day – Psychomotor retardation or agitation (objective) – Loss of energy nearly every day – Worthlessness or guilt nearly every day – Decreased concentration – Suicidality/passive death wish  Symptoms cause clinically significant distress or impairment  Symptoms are not better accounted for by another psych illness  Symptoms are not due to the direct physiological effects of a substance or GMC Minor Depression Subsyndromal presentation  It is now introduced as a DSM IV category  Much more seen in community samples  It is considered to represent a spectrum:  – Prodromal/residual symptoms of MDE – Occurs in patients with underlying medical condition and dementing processes – The consequences on functional capacity are substantial Proposed Diagnostic Criteria   1) Presence of low mood and/or loss of interest in all activities most of the day, nearly every day, and 2) At least two additional symptoms from the DSM checklist: a. Significant weight loss when not dieting or weight gain (e.g., a change in more than 5% of body weight in 1 month), or decrease or increase in appetite nearly every day b. Insomnia or hypersomnia nearly every day c. Psychomotor retardation or agitation nearly every day (observable by others, not merely subjective feelings of restlessness or being slowed down) d. Fatigue or loss of energy nearly every day e. Feelings of worthlessness or excessive or inappropriate guilt) which may be delusional) nearly every day (not merely self-reproach or guilt about being sick) f. Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as observed by others) g. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide Proposed Diagnostic Criteria (Cont.) The symptoms cause clinically significant distress or impairment in social and occupational functioning 4) 17 item Hamilton Rating Scale for Depression (Ham-D) score of >10, or Geriatric Depression Scale Score of >12 5) Duration of at least 1 month Duration subtypes: a. Duration from 1-6 months b. Duration from 6-24 months c. Duration >24 months 3) Proposed Diagnostic Criteria (Cont.) 6) 7) The symptoms may be associated with precipitaing events (e.g., loss of significant other) Organic criteria: - objective evidence from physical and neurological examination and laboratory tests; and/or history of cerebral disease, damage, or dysfunction, or of systemic physical disorder known to cause cerebral dysfunction; including hormonal disturbances and drug effects - a presumed relationship between the development or exacerbation of the underlying disease and clinically significant depression - the disturbance occurs exclusively to the direct psychological effect of alcohol or a substance use - recovery or significant improvement of the depressive symptoms following removal or improvement of the underlying presumed cause Proposed Diagnostic Criteria (Cont.) 8) Exclusion criteria: There has never been: an episode or mania or hypomania; a chronic psychotic disorder, such as schizophrenia or delusional disorders. Previous history of major depressive episode is not an exclusion criterion. Depression and Medical Illness   Medical illness greatly increases riskf or depression Risk to particularly high in – – – – – – –   Ischemic heart disease (e.g., MI, CABG) Stroke Cancer Chronic lung disease Arthritis Alzheimer’s disease Parkinson’s disease Mechanisms of depression vary Medical Illness may confuse the diagnosis of depression in medical patients Depression Due to Medical Condition Older age of onset  Organic features on MSE  Lower incidence of family hx of depression  Less likely to have SI/HI  More likely to improve at discharge  Higher morbidity and mortality in CAD, MI and CVA  Atypical presentation  Medications Associated With Depression and Anxiety Anticancer Cimetidine, cyclotherine, other, levodopa, ranitidine Anticholinergic Amopine, benztropine, hycosamine, probanthine Anti-inflammatory/ anti-infective Baclofen, disulfirma, ethambutol, fenoprofen, indomethacin, naproxen, phenylbutazone, sulfonamides Cardiovascular Bethanidine, clonidine, diuretics, guanethidine, hydralazine, methyldopa, propranolol, reserpine, thiazide Hormones Anabolic steroids, corticotrophin, estrogen hormone blocker, glucocorticoids, oral contraceptives Psychotropics Benzodiazepines, neuroleptics Stimulants Caffeine, nicotine Sympathomimetics Appetite suppressants, ephedrine, pseudoephedrine Withdrawal from: Alcohol, amphetamines, cocaine, hypnotics, sedatives M a d Maddux RE, De;rajo, LL. Ra[a[prt <J. CMS S[pectr/ Vp; 8, No 12 (Suppl 3). 2003. Drugs Linked to Depression/Anxiety          Beta-blockers Other antihypertensives Reserpine Digoxia L-Dopa Steroids Benzodiazepines Phenobarbital Neuroleptics “Masked” Depression         Terminal insomnia, often with ruminations Decreased appetite and weight loss Extreme fatigue vs. anxiousness, restlessness Increased, frequently delusional, preoccupation with bodily functions, pain and weakness Expression of fears and anxiety without reason Low self-esteem or self-concept Increased isolation, loss of interest and pleasure Hopelessness, suicidal ideation – All in context of “not feeling well physically” – Depression is felt to be “secondary” Clues to Depression in Primary Care  Help-seeking, persistent complaints Pain Arthritis Weight Loss Insomnia GI Symptoms Multiple diffuse symptoms Headache • Frequent calls and visits • High utilization of services •Treatment refusal, non-compliance Additional Clues in Nursing Home Apathy, withdrawal, isolation  Failure to thrive  Agitation  Delayed rehabilitation  Additional Clues in Hospitalized Patients CABG, hip fracture, MI, stroke, arthritis  Delayed recovery  Treatment refusal  Discharge problem  Chronic Pain and Depression  Study of more than 1000 patients found depression in 1% of patients with one or no pain complaints  12% in patients with 3 or more such complaints Depression and Neurodegenerative Brain Disease Alzheimer’s Dementia  Vascular Dementia/Cerebrovascular Disease  – Apathy – Nondysphoric Depression  Parkinson’s Disease Vascular Depression Cerebrovascular disease can: - predispose - precipitate - perpetuate - a depressive syndrome Risk Factors of Vascular Depression Male gender  Older age  Diabetes Mellitus  Smoking  Risk Factors of Vascular Depression (Cont.) Atrial fibrillation  Left Ventricular Hypertrophy  Higher systolic blood pressure  Angina Pectoris  Congestive Heart Failure  Cerebrovascular Evidence in Late Life Depression Genetic and early life stressors less important  Diffuse brain dysfunction  Cortical atrophy  Diffuse hypometabolism  Cerebrovascular Evidence in Late Life Depression (Cont.) Deep white and gray matter hyperintensities on MRI  Small vessel disease postmortem  Relation between stroke and depression  Localization of Brain Disease in Depression  Hyperintensities in: - left hemisphere deep white matter - left putamen Localization of Brain Disease in Depression (Cont.) • Lesions of: - caudate - frontal lobe - basal ganglia Brain Function Evidence  Hypoactivity of the caudate and frontal regions including - dorsolateral frontal region - inferior orbitofrontal region - medial anterior cingulate Summary of Vascular Mechanisms of Late-Life Depression  Small lesions disrupt critical pathways: - frontostriatal, circuitry and limbic hippocampal connections - damage of the catecholamine neurons by white matter lesions in the pons - Disruption of the orbital frontal cortex control over the serotonergic raphe nuclei Symptoms and Presentation Increased psychomotor retardation  More prominent cognitive impairment  Poor performance on neuropsychological tests  Symptoms and Presentation (Cont.) Less agitation and guilt  Increased disability  Older age of onset  Executive dysfunction and apathy  Two Major Behavioral Symptoms in Late-Life - Apathy - Executive Function Apathy A state of reduced motivation. Types of Apathy Motor apathy - Tendency not to initiate motor activity  Motivational apathy - Absence of motivation to initiate new activities  Emotional apathy - Absence or reduction of emotional interest  Cognitive apathy - Absence of generative ideation  Conditions Associated with Syndrome of Apathy Alzheimer’s Disease  Vascular Disease  Brain Damage  Partially treated depression  Psychotic depression  Schizophrenia  Drug-induced (neuroleptics, SSRI’s, marijuana, amphetamine or cocaine withdrawal)  Other: apathetic hyperthyroidism, lyme dz, chronic fatigue, testosterone deficiency, sleep apnea, etc.  Executive Dysfunction Decreased: • attention • initiation • organization • planning • abstract thinking Screening for Depression  Evidence-based literature is somewhat sparse and at times conflicting  Majority of physicians would rely on individual judgment when assessing depression in the elderly Overview of Currently Used Depression Scales in Geriatric Patients  When using screening instruments in elderly patients it is important to consider the cognitive level – Visual auditory deficits – Function level  The validity of certain depression screening instruments is significantly decreased in patients with MMSE lower or equal to 15 Geriatric Depression Scale (GDS)           30 questions that indicate presence of depression Yes/No format Might be more appropriate for elderly patients Sensitivity 92% Specificity 89% Valid measure of depression in elderly patients Validity decreases in nursing home patients and appears to be dependent on the degree of cognitive impairment Can be used in inpatient and outpatient Very reliable for phone screening Available for minorities Depression Scale for People with Dementia (Cornell Scale for Depression in Dementia or CSDD) Best validated scale for patients with dementia  Use information from both patients and outside informant  Better validated for patients with mild and moderate dementia than with severe form  Could depict depression in patients with Alzheimer's.  Montgomery/Asperg Depression Rating Scale (MADRS) Observer rated assessment  Based on clinical interview  Does not assess somatic symptoms that are important in geriatric population  Not very well validated in geriatric patients  Zung Self-Rating Depression Scale Self assessment scale  Uses graded answers (never, sometimes, always, usually which might be problematic for geriatric patients)  High false positive results in normal elderly  High false negative results if patients has somantic problems62  Beck Depression Inventory (BDI) Developed by Beck, Steer & Brown  Assesses the intensity of depressive symptoms  5-10 minutes to administer  Highly reliable regardless of the population tested  Available in Spanish  Hamilton Rating Scale for Depression Goal standard of observer-rated depression scale  Requires training to complete  Takes 20-25 minutes to administer  Valid for all ages  Can be used in both clinical and research  Assesses the severity of depression  Screening Measures for Depression in Children, Adolescents, Adults, and the Elderly Measure Spanish Version No of Items Time to Complete Psychometric properties/cutoff ELDERLY Beck Depression Inventory (BDI) Yes 21 5 to 10 Alpha: 0.76/above 15 Center for Epidemiological Studies Depression Scale (CES-D) Yes 20 5 to 10 Sensitivity: 92% Specificity: 87%/above 15 Cornell Scale for Depression in Dementia NO 19 10 with patient, 20 with caregiver Sensitivity: 90% Specificity: 75%/above 12 Geriatric Depression Scale (GDS) Yes 30 10 to 15 Specificity: 100%/above 13 Sensitivity: 92% to 97% Geriatric Depression Scaleshort Yes 15 5 to 10 Specificity: 64.8% to 81%/above 5 Zung Depression Rating Scale No 20 5 to 10 Specificity: 63%/above 49 Medications Useful in Treating Depression Medication Doses Ranger Uses Precautions Selective Serotonin Reuptake Inhibitors Citalopram Fluoxetine Paroxetine Sertraline Trazodone 10-40 mg/day 10-40 mg/day 10-40 mg/day 25-100 mg/day 25-150 mg/day Depression, Dysthymia, anxiety Common to all SSRIs Common to all SSRIs Common to all SSRIs When sedation is desirable GI upset, nausea, vomiting, insomnia Tricyclic Antidepressants Desipramine 10-100 mg/day Anticholinergic effects, hypotension, sedation, cardiac arrhythmias Nortriptyline 10-75 mg/day Adjunctive pain management/ neuropathic pain naturopathic pain High efficacy for depression if patient can tolerate side effects Other Agents Buproprion 75-225 mg/day Irritability, insomnia Mirtazapine Nefazodone 7.5-30 mg/day 50-200 mg/day More activating, lack of cardiac effects Useful for insomnia Useful for insomnia Vanlafaxine 25-150 mg/day Useful in severe depression 2.5-20 mg/day Give before 1PM Ofen rapid onset may augment antidepressants 2.5-15 mg/day Give before 1PM Same as above Psychostimulants Methylphenidate Dextroamphetamine Sedation, falls, hypotension Sedation, hypotension Sedation, hypotension *Warning, do not use in liver disease Hypertension may be a problem; insomnia Tachycardia, irritability, tremor, excitation, insomnia Similar, but possibly More over-stimulation Psychosocial Interventions for Depression Social support to reduce isolation; referral to senior centers, home care, and visiting nurse services; pet therapy and visitation; volunteer jobs as indicated  Psychotherapy: supportive psychotherapy, cognitivebehavioral therapy, interpersonal therapy, group therapy  Family counseling  Substance abuse interventions as indicated  Bereavement counseling and services as needed  Health promotion and maintenance: good nutrition, light physical exercise, attention to chronic medical conditions, establish a regular daily routine  Conclusion  When diagnosing depression in geriatric patients, there are 5 essential objectives: – Determine etiology and diagnosis – Provide disease specific management – Manage behaviors and target symptoms (symptoms that are the most distressing) – Prevent secondary complications (side effects of medication) – Rule out dementing process/medical illness – Support the families
© Copyright 2025